KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
77 hedge funds and large institutions have $328M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
55% less call options, than puts
Call options by funds: $493K | Put options by funds: $1.09M
Holders
77
Holding in Top 10
2
Calls
$493K
Puts
$1.09M
Top Buyers
| 1 | +$63.9M | |
| 2 | +$19.8M | |
| 3 | +$19.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$11.9M |
Top Sellers
| 1 | -$1.58M | |
| 2 | -$1.38M | |
| 3 | -$1.22M | |
| 4 |
Renaissance Technologies
New York
|
-$646K |
| 5 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$330K |